Cello to rebrand pharmaceutical services as ‘Cello Health’
Insight and strategic marketing group Cello has announced plans to rebrand its pharmaceutical services as ‘Cello Health’, part of moves to have the division operate under a single structure.
This strategy will also see Cello Health joined by specialist brand consultancy professionals from the group to develop their consumer health proposition to be targeted at brand owners with a strong customer health proposition.
In tandem with this move consumer centric businesses will be grouped into a single division known as Cello Consumer. Incorporating communications and consumer insight this is intended to give the division the necessary firepower to compete in the US.
Mark Scott, Cello Chief Executive, commented: "Cello's strategy of focusing on the pharmaceutical sector with high value advisory services continues to bear fruit. The reorganisation of the Group behind this strategy will further galvanise our leadership position in this area. The Group will continue to invest behind increasing its exposure to international client markets as a primary driver of growth, both in the pharmaceutical and other high margin client sectors."